BLOODPAC Hosts Brain Cancer Virtual Webinar

On March 30, BLOODPAC partnered with the Focused Ultrasound Foundation and C2i Genomics to host a virtual webinar, “New Frontiers in Liquid Biopsy: Personalized Medicine for Brain Cancer in Adults and Children.” The workshop featured prominent researchers in the field, and explored the potential uses of liquid biopsy for patients with brain tumors. All talk recordings are now available to watch here.

The speakers included Nir Lipsman, MD/PhD, a pioneer in focused ultrasound applications for the brain, and Manmeet Ahluwalia, MD, who will lead a clinical trial assessing the efficacy of liquid biopsy for recurrence monitoring of patients with primary brain cancer. The session also featured presentations by Stephen Bagley, MD and Matija Snuderi, MD. Panelists Kirk Tanner, PhD, from the National Brain Tumor Society; Patrick Wen, MD, from the Dana Farber Cancer Institute; Lauren Abrey, MD, from Novartis; and Uri Weinberg, MD, PhD, from Novocure discussed key barriers, identified challenges, and began creating a roadmap to move the field forward.


Related Posts

Previous
Previous

BLOODPAC Publishes a Roadmap for Early Cancer Detection and Screening using Liquid Biopsy

Next
Next

BLOODPAC and Epic Sciences: Building Collaboration